Is a complete CATX research report available?

No complete published report is available for Perspective Therapeutics, Inc. (CATX) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Perspective Therapeutics, Inc. (CATX)

NYSEAMERICAN: CATX · USD

$1.21

+0.01 (+1.3%)· Recorded snapshot

Market cap	137.6M
Revenue (ttm)	409K
Net income (ttm)	-116.4M
EPS (ttm)	-$1.25
Shares out	114.2M
Volume	4,337,214
Beta	1.85

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 409K
Net income (ttm): -116.4M
EPS (ttm): -$1.25
Market cap: 137.6M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

Metric	Value
Amount currency	USD
CIK code	0000728387
Company name	Perspective Therapeutics, Inc.
Country	United States
Country code	US
CUSIP number	46489V302
Earnings date	2026-11-09
Earnings time	amc
Employees	166
Employees change	26
Employees growth	18.57%
Enterprise value	$-95.4M
Exchange	NYSEAMERICAN
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1983
In index	RUSSELL2000
Industry	Medical Devices
Is primary listing	Yes
Is SPAC	No
ISIN number	US46489V3024
Last 10-K release date	2026-03-16
Last earnings date	2026-08-10
Last refreshed	2026-10-28
Last stock split date	2024-06-17
Last stock split type	Reverse
Market cap	$137.6M
Market cap category	Micro-Cap
Next earnings date	2026-11-09
Options	Yes
Price	$1.21
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	CATX
U.S. state	Washington
Website	https://www.perspectivetherapeutics.com

Metric

Value

Amount currency

USD

CIK code

0000728387

Company name

Perspective Therapeutics, Inc.

Country

United States

Country code

CUSIP number

46489V302

Earnings date

2026-11-09

Earnings time

amc

Employees

166

Employees change

Employees growth

18.57%

Enterprise value

$-95.4M

Exchange

NYSEAMERICAN

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

1983

In index

RUSSELL2000

Industry

Medical Devices

Is primary listing

Yes

Is SPAC

ISIN number

US46489V3024

Last 10-K release date

2026-03-16

Last earnings date

2026-08-10

Last refreshed

2026-10-28

Last stock split date

2024-06-17

Last stock split type

Reverse

Market cap

$137.6M

Market cap category

Micro-Cap

Next earnings date

2026-11-09

Options

Yes

Price

$1.21

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

CATX

U.S. state

Washington

Website

https://www.perspectivetherapeutics.com

Metric	Value
Earnings yield	-103.62%
FCF / EV yield	124.84%
FCF yield	-89.21%
Forward P/S	742.66x
Industry forward P/E	19.74x
Industry P/E	39.16x
P/B ratio	0.42x
P/S ratio	332.13x
Price / tangible book value	0.48x
Sector forward P/E	23.56x
Sector P/E	50.08x

Metric

Value

Earnings yield

-103.62%

FCF / EV yield

124.84%

FCF yield

-89.21%

Forward P/S

742.66x

Industry forward P/E

19.74x

Industry P/E

39.16x

P/B ratio

0.42x

P/S ratio

332.13x

Price / tangible book value

0.48x

Sector forward P/E

23.56x

Sector P/E

50.08x

Metric	Value
Operating margin	-30,619.07%
Pretax margin	-28,710.02%
Profit per employee	$-701,410
Revenue per employee	$2,464
ROA	-22.28%
ROCE	-35.23%
ROE	-39.57%
ROIC	-26.22%
SBC / revenue	2,460.64%
Tax / revenue	-193.89%

Metric

Value

Operating margin

-30,619.07%

Pretax margin

-28,710.02%

Profit per employee

$-701,410

Revenue per employee

$2,464

ROA

-22.28%

ROCE

-35.23%

ROE

-39.57%

ROIC

-26.22%

SBC / revenue

2,460.64%

Tax / revenue

-193.89%

Metric	Value
EPS growth quarters	1
EPS growth years	0
Net income growth years	0
Revenue growth	-66.88%
Revenue growth (Q)	-72.07%
Revenue growth (QoQ)	6.58%
Revenue growth 10Y	-21.78%
Revenue growth 3Y	-20.73%
Revenue growth 5Y	-47.29%
Revenue growth years	0

Metric

Value

EPS growth quarters

EPS growth years

Net income growth years

Revenue growth

-66.88%

Revenue growth (Q)

-72.07%

Revenue growth (QoQ)

6.58%

Revenue growth 10Y

-21.78%

Revenue growth 3Y

-20.73%

Revenue growth 5Y

-47.29%

Revenue growth years

Metric	Value
Capital expenditures	$-28.1M
Depreciation and amortization	$4M
EBIT	$-125.2M
EBITDA	$-121.2M
EPS	$-1.25
FCF per share	$-1.06
Financing cash flow	$164.7M
Free cash flow	$-121.2M
Free cash flow minus SBC	$-131.3M
Gross profit	$-95.8M
Income taxes	$-793,000
Investing cash flow	$-52M
Net borrowing	$-54,000
Net cash flow	$19.6M
Net income	$-116.4M
Operating cash flow minus SBC	$-103.1M
Operating income	$-125.2M
Revenue	$409,000
Stock-based compensation	$10.1M

Metric

Value

Capital expenditures

$-28.1M

Depreciation and amortization

$4M

EBIT

$-125.2M

EBITDA

$-121.2M

EPS

$-1.25

FCF per share

$-1.06

Financing cash flow

$164.7M

Free cash flow

$-121.2M

Free cash flow minus SBC

$-131.3M

Gross profit

$-95.8M

Income taxes

$-793,000

Investing cash flow

$-52M

Net borrowing

$-54,000

Net cash flow

$19.6M

Net income

$-116.4M

Operating cash flow minus SBC

$-103.1M

Operating income

$-125.2M

Revenue

$409,000

Stock-based compensation

$10.1M

Metric	Value
Altman Z-Score	1.15
Book value per share	$2.84
Debt / equity	0.01
Interest coverage	-410.6
Long-term assets	$150.5M
Long-term liabilities	$31.6M
Net cash (debt)	$232.9M
Net cash / market cap	171.46%
Net cash growth	23.88%
Net debt / equity	-0.72
Piotroski F-Score	2
Property, plant and equipment	$110M
Shareholders' equity	$323.9M
Tangible book value	$283.9M
Tangible book value per share	$2.49
Total assets	$392M
Total cash	$236.9M
Total debt	$4M
Total liabilities	$68.2M
WACC	14.19%

Metric

Value

Altman Z-Score

1.15

Book value per share

$2.84

Debt / equity

0.01

Interest coverage

-410.6

Long-term assets

$150.5M

Long-term liabilities

$31.6M

Net cash (debt)

$232.9M

Net cash / market cap

171.46%

Net cash growth

23.88%

Net debt / equity

-0.72

Piotroski F-Score

Property, plant and equipment

$110M

Shareholders' equity

$323.9M

Tangible book value

$283.9M

Tangible book value per share

$2.49

Total assets

$392M

Total cash

$236.9M

Total debt

$4M

Total liabilities

$68.2M

WACC

14.19%

Metric	Value
Asset turnover	0
Current assets	$241.5M
Current liabilities	$36.5M
Current ratio	6.61
Net working capital	$-30.7M
Quick ratio	6.49
Working capital	$205M
Working capital turnover	0

Metric

Value

Asset turnover

Current assets

$241.5M

Current liabilities

$36.5M

Current ratio

6.61

Net working capital

$-30.7M

Quick ratio

6.49

Working capital

$205M

Working capital turnover

Metric	Value
Buyback yield / dilution	-29.45%
Dividend yield	0%
Shareholder yield	-29.45%

Metric

Value

Buyback yield / dilution

-29.45%

Dividend yield

Shareholder yield

-29.45%

Metric	Value
10Y price change	-80.25%
10Y return CAGR	-14.97%
10Y total return	-80.25%
150-day SMA	$3.26
15Y price change	-84.55%
15Y return CAGR	-11.71%
15Y total return	-84.55%
1D price change	1.26%
1M price change	-52.18%
1M total return	-52.18%
1W price change	-47.61%
1W total return	-47.61%
1Y price change	-61.13%
1Y return CAGR	-61.15%
1Y total return	-61.13%
20-day SMA	$2.20
200-day SMA	$3.55
20Y price change	-97.16%
20Y return CAGR	-16.31%
20Y total return	-97.16%
3M price change	-57.27%
3M total return	-57.27%
3Y price change	-53.65%
3Y return CAGR	-22.61%
3Y total return	-53.65%
50-day SMA	$2.66
50-day SMA vs 200-day SMA	50under200
52-week high	$6.16
52-week high date	2026-01-29
52-week low	$1.06
52-week low date	2026-10-27
5Y price change	-80.56%
5Y return CAGR	-27.94%
5Y total return	-80.56%
6M price change	-71.78%
6M total return	-71.78%
All-time high	$85.00
All-time high date	2005-12-15
All-time low	$1.06
All-time low date	2026-10-27
Average true range (ATR)	$0.23
Average volume	2.8M
Beta (1Y)	1.97
Beta (2Y)	1.64
Beta (5Y)	1.85
Change from 52-week high	-80.44%
Change from 52-week low	13.68%
Change from all-time high	-98.58%
Change from all-time low	13.68%
Change from open	0.42%
Day's gap	0.84%
Dollar volume	$5.2M
High price	$1.24
Low price	$1.07
Monthly RSI	38.21
Open price	$1.20
Position in 52-week range	79.41%
Premarket change	0.87%
Premarket close	$1.19
Premarket price	$1.20
Premarket volume	29.2K
Previous close	$1.19
Price vs 150-day SMA	-63%
Price vs 20-day SMA	-45.28%
Price vs 200-day SMA	-66.09%
Price vs 50-day SMA	-54.63%
Relative volume	1.6
RSI	21.85
Sharpe ratio	-0.41
Sharpe ratio (3Y)	0.24
Sharpe ratio (5Y)	0.14
Sortino ratio	-0.62
Sortino ratio (3Y)	0.42
Sortino ratio (5Y)	0.28
Volume	4.3M
Weekly RSI	25.29
YTD price change	-56.18%
YTD total return	-56.18%

Metric

Value

10Y price change

-80.25%

10Y return CAGR

-14.97%

10Y total return

-80.25%

150-day SMA

$3.26

15Y price change

-84.55%

15Y return CAGR

-11.71%

15Y total return

-84.55%

1D price change

1.26%

1M price change

-52.18%

1M total return

-52.18%

1W price change

-47.61%

1W total return

-47.61%

1Y price change

-61.13%

1Y return CAGR

-61.15%

1Y total return

-61.13%

20-day SMA

$2.20

200-day SMA

$3.55

20Y price change

-97.16%

20Y return CAGR

-16.31%

20Y total return

-97.16%

3M price change

-57.27%

3M total return

-57.27%

3Y price change

-53.65%

3Y return CAGR

-22.61%

3Y total return

-53.65%

50-day SMA

$2.66

50-day SMA vs 200-day SMA

50under200

52-week high

$6.16

52-week high date

2026-01-29

52-week low

$1.06

52-week low date

2026-10-27

5Y price change

-80.56%

5Y return CAGR

-27.94%

5Y total return

-80.56%

6M price change

-71.78%

6M total return

-71.78%

All-time high

$85.00

All-time high date

2005-12-15

All-time low

$1.06

All-time low date

2026-10-27

Average true range (ATR)

$0.23

Average volume

2.8M

Beta (1Y)

1.97

Beta (2Y)

1.64

Beta (5Y)

1.85

Change from 52-week high

-80.44%

Change from 52-week low

13.68%

Change from all-time high

-98.58%

Change from all-time low

13.68%

Change from open

0.42%

Day's gap

0.84%

Dollar volume

$5.2M

High price

$1.24

Low price

$1.07

Monthly RSI

38.21

Open price

$1.20

Position in 52-week range

79.41%

Premarket change

0.87%

Premarket close

$1.19

Premarket price

$1.20

Premarket volume

29.2K

Previous close

$1.19

Price vs 150-day SMA

-63%

Price vs 20-day SMA

-45.28%

Price vs 200-day SMA

-66.09%

Price vs 50-day SMA

-54.63%

Relative volume

1.6

RSI

21.85

Sharpe ratio

-0.41

Sharpe ratio (3Y)

0.24

Sharpe ratio (5Y)

0.14

Sortino ratio

-0.62

Sortino ratio (3Y)

0.42

Sortino ratio (5Y)

0.28

Volume

4.3M

Weekly RSI

25.29

YTD price change

-56.18%

YTD total return

-56.18%

Metric	Value
Float	70.8M
Float percentage	62.04%
Shares change (QoQ)	16.45%
Shares change (YoY)	29.45%
Shares held by insiders	0.57%
Shares held by institutions	55.49%
Shares outstanding	114.2M
Short % of float	23.4%
Short % of shares	14.52%
Short ratio	7.7 days

Metric

Value

Float

70.8M

Float percentage

62.04%

Shares change (QoQ)

16.45%

Shares change (YoY)

29.45%

Shares held by insiders

0.57%

Shares held by institutions

55.49%

Shares outstanding

114.2M

Short % of float

23.4%

Short % of shares

14.52%

Short ratio

7.7 days

Perspective Therapeutics, Inc. (CATX)

Price

Financial snapshot

Fair-value bridge

Latest news · CATX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CATX indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on CATX

Frequently asked questions